Provides empirical, personalized drug-response data and lab-developed tests (LDTs) to inform oncologists' treatment selection for specific cancer indications. Develops an automated cancer diagnostic instrument to scale assays and offers 10x Genomics–certified single-cell analysis services for clinical and preclinical studies.